Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use

Ítems similars

• Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
  per: Duintjer Tebbens, Radboud J., et al.
  Publicat: (2016)
• Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes
  per: Thompson, Kimberly M., et al.
  Publicat: (2017)
• Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
  per: Duintjer Tebbens, Radboud J., et al.
  Publicat: (2018)
• Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
  per: Thompson, Kimberly M., et al.
  Publicat: (2015)
• Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use
  per: Duintjer Tebbens, Radboud J., et al.
  Publicat: (2017)